SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The prediction of drug–target affinity (DTA) is a crucial step for drug screening and discovery. In this study, a new graph-based prediction model named SAG-DTA (self-attention graph drug–target affinity) was implemented. Unlike previous graph-based methods, the proposed model utilized self-attention mechanisms on the drug molecular graph to obtain effective representations of drugs for DTA prediction. Features of each atom node in the molecular graph were weighted using an attention score before being aggregated as molecule representation. Various self-attention scoring methods were compared in this study. In addition, two pooing architectures, namely, global and hierarchical architectures, were presented and evaluated on benchmark datasets. Results of comparative experiments on both regression and binary classification tasks showed that SAG-DTA was superior to previous sequence-based or other graph-based methods and exhibited good generalization ability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Graph neural networks: A review of methods and applications
Zhou, J., Cui, G., Hu, S., Zhang, Z., Yang, C., Liu, Z., Wang, L., Li, C., & Sun, M. (2020) · AI Open · doi:10.1016/j.aiopen.2021.01.001 · Cited by 6,880
Graph Neural Networks: A Review of Methods and Applications
Zhou, J., Cui, G., Hu, S., Zhang, Z., Yang, C., Liu, Z., Wang, L., Li, C., & Sun, M. (2018) · arXiv · doi:10.48550/arxiv.1812.08434 · Cited by 6,880
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359 · cited 1×
“Developing a new drug that gains marketing approval is estimated to cost USD 2.6 billion, and the approval rate for drugs entering clinical development is less than 12% [1,2].”
BackgroundInfluentialComprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
QSAR Modeling: Where have you been? Where are you going to?
Cherkasov, A., Muratov, E. N., Fourches, D., Varnek, A., Baskin, I. I., Cronin, M., Dearden, J., Gramatica, P., Martin, Y. C., Todeschini, R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4004285 · Cited by 2,164
Tsubaki, M., Tomii, K., & Sese, J. (2019) · Bioinformatics · doi:10.1093/bioinformatics/bty535 · Cited by 688 · cited 2×
“On the Human dataset, SAG-DTA was compared to traditional machine learning algorithms, including k-nearest neighbors (k-NN); random forest (RF); L2-logistic (L2); support vector machines (SVMs); and some recent graph-based approaches, such as CPI-GNN [22], DrugVQA [42], and TransformerCPI [43].”
MethodSuperTarget and Matador: resources for exploring drug-target relationships
Gunther, S., Kuhn, M., Dunkel, M., Campillos, M., Senger, C., Petsalaki, E., Ahmed, J., Urdiales, E. G., Gewiess, A., Jensen, L. J., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm862 · Cited by 647 · cited 1×
“The Human dataset includes positive CPI pairs derived from DrugBank [32] and Matador [33], and it is characterized by the highly credible negative CPI samples.”
MethodChen, L., Tan, X., Wang, D., Zhong, F., Liu, X., Yang, T., Luo, X., Chen, K., Jiang, H., & Zheng, M. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa524 · Cited by 607 · cited 2×
“The performances of these models were obtained from [43] and are summarized in Table 6.”
MethodDeepCPI: A Deep Learning-Based Framework for Large-Scale in Silico Drug Screening
Wan, F., Zhu, Y., Hu, H., Dai, A., Cai, X., Chen, L., Gong, H., Xia, T., Yang, D., Wang, M.-W., et al. (2019) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.04.003 · Cited by 92
Cited by
Attention is all you need: utilizing attention in AI-enabled drug discovery
Zhang, Y., Liu, C., Liu, M., Liu, T., Lin, H., Huang, C.-B., & Ning, L. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad467 · Cited by 377
Deep learning methods for molecular representation and property prediction
Li, Z., Jiang, M., Wang, S., & Zhang, S. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103373 · Cited by 279
Self-citationBreaking the barriers of data scarcity in drug–target affinity prediction
Pei, Q., Wu, L., Zhu, J., Xia, Y., Xie, S., Qin, T., Liu, H., Liu, T.-Y., & Yan, R. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad386 · Cited by 36
From Proteins to Ligands: Decoding Deep Learning Methods for Binding Affinity Prediction
Gorantla, R., Kubincová, A., Weiße, A. Y., & Mey, A. S. J. S. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01208 · Cited by 24
DrugForm-DTA: Towards real-world drug-target binding affinity model
Khokhlov, I., Tashchilova, A., Bugaev-Makarovskiy, N., Glushkova, O., Yudin, V., Keskinov, A., Yudin, S., Svetlichnyy, D., & Skvortsova, V. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.09.023 · Cited by 7
Metadata
- Authors
- Zhang, S., Jiang, M., Wang, S., Wang, X., Wei, Z., & Li, Z.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-08-20
- Volume
- 22
- Issue
- 16
- Pages
- 8993
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3194218357
- Cited by
- 65
- References
- 9
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network. https://app.cochat.ai/papers/10.3390/ijms22168993
- The paper
- Zhang, S., Jiang, M., Wang, S., Wang, X., Wei, Z., & Li, Z. (2021). SAG-DTA: Prediction of Drug–Target Affinity Using Self-Attention Graph Network. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22168993
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.